[go: up one dir, main page]

GB202402603D0 - A pouch for transmucosal delivery of an active compound - Google Patents

A pouch for transmucosal delivery of an active compound

Info

Publication number
GB202402603D0
GB202402603D0 GBGB2402603.1A GB202402603A GB202402603D0 GB 202402603 D0 GB202402603 D0 GB 202402603D0 GB 202402603 A GB202402603 A GB 202402603A GB 202402603 D0 GB202402603 D0 GB 202402603D0
Authority
GB
United Kingdom
Prior art keywords
pouch
active compound
transmucosal delivery
transmucosal
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2402603.1A
Other versions
GB2638465A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
State Mode Medical Ltd
Original Assignee
State Mode Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by State Mode Medical Ltd filed Critical State Mode Medical Ltd
Priority to GB2402603.1A priority Critical patent/GB2638465A/en
Publication of GB202402603D0 publication Critical patent/GB202402603D0/en
Priority to PCT/EP2025/054918 priority patent/WO2025176912A1/en
Publication of GB2638465A publication Critical patent/GB2638465A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
GB2402603.1A 2024-02-23 2024-02-23 A pouch for transmucosal delivery of an active compound Pending GB2638465A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2402603.1A GB2638465A (en) 2024-02-23 2024-02-23 A pouch for transmucosal delivery of an active compound
PCT/EP2025/054918 WO2025176912A1 (en) 2024-02-23 2025-02-24 A pouch for transmucosal delivery of an active compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2402603.1A GB2638465A (en) 2024-02-23 2024-02-23 A pouch for transmucosal delivery of an active compound

Publications (2)

Publication Number Publication Date
GB202402603D0 true GB202402603D0 (en) 2024-04-10
GB2638465A GB2638465A (en) 2025-08-27

Family

ID=90572523

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2402603.1A Pending GB2638465A (en) 2024-02-23 2024-02-23 A pouch for transmucosal delivery of an active compound

Country Status (2)

Country Link
GB (1) GB2638465A (en)
WO (1) WO2025176912A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7810507B2 (en) * 2006-02-10 2010-10-12 R. J. Reynolds Tobacco Company Smokeless tobacco composition
PH12022551272A1 (en) * 2019-12-09 2023-11-29 Nicoventures Trading Ltd Oral product with dissolvable component
US20220225660A1 (en) * 2019-12-09 2022-07-21 Nicoventures Trading Limited Pouched products with heat sealable binder
EP4018848B1 (en) * 2020-12-22 2024-09-18 Swedish Match North Europe AB A pouched product for oral use comprising a liquid permeable cover material and a filling material
US20220331344A1 (en) * 2021-04-15 2022-10-20 Resurgent Biosciences, Inc Oral formulations of psychotropic macrofungus botanical extracts with mouthfeel experience enhancers

Also Published As

Publication number Publication date
GB2638465A (en) 2025-08-27
WO2025176912A1 (en) 2025-08-28

Similar Documents

Publication Publication Date Title
EP4595962A3 (en) Pharmaceutical composition
GB202402603D0 (en) A pouch for transmucosal delivery of an active compound
PT4489884T (en) A method for crystallization of active pharmaceutical ingredients
GB202311643D0 (en) Transmucosal deliver of a drug
CA233986S (en) Dispenser for packaging
GB202507186D0 (en) Compositions for a substance delivery system
GB202507189D0 (en) Compositions for a substance delivery system
GB202501490D0 (en) Implant for delivery of a drug
CA244591S (en) Aerosol delivery device
CA3279783A1 (en) System for oral delivery of an active ingredient
CA234190S (en) Dispenser [packaging]
CA222478S (en) Part of blister package
CA222477S (en) Part of blister package
CA222483S (en) Part of blister package
CA222482S (en) Part of blister package
CA222479S (en) Part of blister package
CA222476S (en) Part of blister package
GB202418321D0 (en) Next generation delivery of antimicrobial peptides
GB202408767D0 (en) a package
AU2023902019A0 (en) Injectable composition for delivery of a biologically active agent
CA3231194A1 (en) Active tensioning for electrolyzer stacks
CA236955S (en) Blister pack [packaging]
GB202017724D0 (en) Pharmaceutically active compound formulations
GB202505025D0 (en) Pharmaceutical compositions comprising 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt)
GB202500245D0 (en) Drug delivery